Literature DB >> 8463392

Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections.

J C Russi1, A Delfraro, M D Borthagaray, B Velazquez, B García-Barreno, M Hortal.   

Abstract

Enzyme immunoassays were developed to detect the presence of specific immunoglobulin E (IgE) antibodies and respiratory syncytial (RS) virus structural proteins in nasopharyngeal secretions in order to improve the knowledge on some aspects of the pathogenesis of severe acute lower respiratory tract infections caused by RS virus. These assays were used to analyze clinical specimens from children with RS virus-associated infections (bronchiolitis and pneumonia), and the findings were correlated with the patients' clinical symptoms. The results indicate the presence of specific IgE against the two external glycoproteins (G and F) and the absence of detectable IgE levels for the internal viral antigens. There was a correlation between the levels of IgE-specific antibodies and the amount of viral protein F in the secretions, indicating that the IgE response against the viral glycoproteins might be related to the antigen load. In addition, a correlation was found between higher levels of both viral protein F-specific IgE and F antigen with higher respiratory rates in children with pneumonia. These findings may be relevant because they suggest an association between the virus load and the immune response in the pathogenesis of RS virus infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463392      PMCID: PMC263570          DOI: 10.1128/jcm.31.4.819-823.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection.

Authors:  R C Welliver; M Sun; S W Hildreth; R Arumugham; P L Ogra
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

3.  Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.

Authors:  B García-Barreno; C Palomo; C Peñas; T Delgado; P Perez-Breña; J A Melero
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus.

Authors:  R H Bui; G A Molinaro; J D Kettering; D C Heiner; D T Imagawa; J W St Geme
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

5.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection.

Authors:  H W Kim; J O Arrobio; C D Brandt; B C Jeffries; G Pyles; J L Reid; R M Chanock; R H Parrott
Journal:  Am J Epidemiol       Date:  1973-09       Impact factor: 4.897

6.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

7.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors:  A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

Review 8.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

9.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

10.  Respiratory syncytial virus infections in infants: quantitation and duration of shedding.

Authors:  C B Hall; R G Douglas; J M Geiman
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

View more
  14 in total

1.  Undetectable IgE responses after respiratory syncytial virus infection.

Authors:  G L Toms; R Quinn; J W Robinson
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 2.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 3.  Role of viruses in the development of atopic disease in pediatric patients.

Authors:  Dorothy S Cheung; Mitchell H Grayson
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

Review 4.  Respiratory viral infections and atopic development: From possible mechanisms to advances in treatment.

Authors:  Lisa M Martorano; Mitchell H Grayson
Journal:  Eur J Immunol       Date:  2018-01-15       Impact factor: 5.532

Review 5.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 6.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

7.  Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine.

Authors:  Tamar A Smith-Norowitz; Darrin Wong; Melanie Kusonruksa; Kevin B Norowitz; Rauno Joks; Helen G Durkin; Martin H Bluth
Journal:  Int J Med Sci       Date:  2011-03-18       Impact factor: 3.738

8.  Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus Vaccine.

Authors:  Tamar A Smith-Norowitz; Joby Josekutty; Jonathan I Silverberg; Hadar Lev-Tov; Yitzchok M Norowitz; Stephan Kohlhoff; Maja Nowakowski; Helen G Durkin; Martin H Bluth
Journal:  Int J Biomed Sci       Date:  2009-12

9.  Need for a safe vaccine against respiratory syncytial virus infection.

Authors:  Joo-Young Kim; Jun Chang
Journal:  Korean J Pediatr       Date:  2012-09-14

10.  Cellular and humoral immunity of virus-induced asthma.

Authors:  Yoshimichi Okayama
Journal:  Front Microbiol       Date:  2013-08-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.